ESC Premium Access

Effect of beta-blockers on mortality in heart failure with mid-range and preserved ejection fraction: a meta-analysis

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Presentation

About the speaker

Associate Professor Hidekatsu Fukuta

Nagoya City University Graduate School of Medical Sciences, Nagoya (Japan)
0 follower

9 more presentations in this session

Comparative efficacy of renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with reduced, mid-ranged and preserved ejection fraction

Speaker: Professor L. Tumasyan (Yerevan, AM)

Thumbnail

The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction

Speaker: Doctor C. Wei-Ting (Tainan, TW)

Thumbnail

Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study

Speaker: Doctor K. Tsukamoto (Tokyo, JP)

Thumbnail

Natriuretic peptides added to clinical parameters predict two-year prognosis of patients with chronic heart with mid-range and reduced ejection fraction.

Speaker: Professor J. Spinar (Brno, CZ)

Thumbnail

Rehospitalization burden in heart failure with mid-range ejection fraction and morbidity burden. Is it a distinct phenotype?

Speaker: Doctor E. Santas Olmeda (Valencia, ES)

Thumbnail

Access the full session

Poster Session 4 - Heart failure treatment, HFpEF, HFmrEF

Speakers: Associate Professor H. Fukuta, Professor L. Tumasyan, Doctor C. Wei-Ting, Doctor K. Tsukamoto, Professor J. Spinar...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk